Skip to main content
Back to Shenzhen Capital Group

Shenzhen Capital Group's Medical Portfolio

Browse 16 Medical companies funded by Shenzhen Capital Group. See funding amounts, founder contacts, and investment details.

Medical Companies
16
Total Funding in Medical
$405.5M

Medical Portfolio Companies (16)

Export
Artificial Intelligence (AI)Health CareHome Health CareMachine LearningMedical DevicemHealthSoftwareTelehealth

TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.

New York, United States
August 2023
$49.0M
Series E

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CareMedicalTherapeutics

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Woburn, United States
December 2025
$110.0M
Series B

Founder Contacts

19,000+ verified contacts

MedicalMedical DeviceTherapeutics

Better Micro Medical is a medical device company that offers comprehensive solutions for peripheral vascular and structural heart disease.

Shenzhen, China
March 2026
$14.5M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalMedical Device

Transcend Vivoscope is a biotechnology company that specializes in providing advanced microscopy imaging products and solutions.

Haidian, China
February 2026
$14.5M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedical Device

Kai Medtech is a marketing and sales company for vascular intervention medical devices.

Minhang, China
February 2026
Series D

Founder Contacts

19,000+ verified contacts

Health CareHealth DiagnosticsMedical Device

Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment.

Luoyang, China
November 2025
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalProduct Research

Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.

Shanghai, China
October 2025
Series A

Founder Contacts

19,000+ verified contacts

BioinformaticsBiotechnologyGeneticsMedical

Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology and spatial omics products.

Shenzhen, China
October 2025
$7.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyMedical

Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.

Nanjing, China
September 2025
$28.1M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

Nuoyimeier is a developer of implantable consumables.

Suzhou, China
January 2025
$40.8M
Series C

Founder Contacts

19,000+ verified contacts

Health CareHealth DiagnosticsMedicalNuclear

C Ray Therapeutics develops healthcare advancements through nuclear medicine.

Chengdu, China
November 2024
$100.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Wingtech Pharmaceuticals is an innovative pharmaceutical company that develop drugs for the treatment of chronic metabolic diseases.

Suzhou, China
October 2024
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical

MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform.

Haidian, China
September 2024
$14.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedical DeviceRobotics

Puncture Robotic develops venipuncture robots that help in conducting blood collection without human intervention.

Shanghai, China
September 2024
Series B

Founder Contacts

19,000+ verified contacts

ManufacturingMedicalMedical Device

Hannuo Medical is a medical technology company that develops high-end medical devices for critical extracorporeal life support.

Shenzhen, China
June 2024
$13.8M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHospitalMedical

Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies.

Shanghai, China
April 2024
$13.8M
Series A

Founder Contacts

19,000+ verified contacts

Explore Shenzhen Capital Group's Full Portfolio

View all companies funded by Shenzhen Capital Group across every industry and funding stage.

View Full Shenzhen Capital Group Portfolio